248 related articles for article (PubMed ID: 28716504)
1. Series: Pragmatic trials and real world evidence: Paper 8. Data collection and management.
Meinecke AK; Welsing P; Kafatos G; Burke D; Trelle S; Kubin M; Nachbaur G; Egger M; Zuidgeest M;
J Clin Epidemiol; 2017 Nov; 91():13-22. PubMed ID: 28716504
[TBL] [Abstract][Full Text] [Related]
2. Series: Pragmatic trials and real world evidence: Paper 7. Safety, quality and monitoring.
Irving E; van den Bor R; Welsing P; Walsh V; Alfonso-Cristancho R; Harvey C; Garman N; Grobbee DE;
J Clin Epidemiol; 2017 Nov; 91():6-12. PubMed ID: 28502812
[TBL] [Abstract][Full Text] [Related]
3. Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences.
Oude Rengerink K; Kalkman S; Collier S; Ciaglia A; Worsley SD; Lightbourne A; Eckert L; Groenwold RHH; Grobbee DE; Irving EA;
J Clin Epidemiol; 2017 Sep; 89():173-180. PubMed ID: 28502808
[TBL] [Abstract][Full Text] [Related]
4. Series: Pragmatic trials and real world evidence: Paper 1. Introduction.
Zuidgeest MGP; Goetz I; Groenwold RHH; Irving E; van Thiel GJMW; Grobbee DE;
J Clin Epidemiol; 2017 Aug; 88():7-13. PubMed ID: 28549929
[TBL] [Abstract][Full Text] [Related]
5. Series: Pragmatic trials and real world evidence: Paper 4. Informed consent.
Kalkman S; van Thiel GJMW; Zuidgeest MGP; Goetz I; Pfeiffer BM; Grobbee DE; van Delden JJM;
J Clin Epidemiol; 2017 Sep; 89():181-187. PubMed ID: 28502809
[TBL] [Abstract][Full Text] [Related]
6. Pragmatic clinical trials in the context of regulation of medicines.
Gedeborg R; Cline C; Zethelius B; Salmonson T
Ups J Med Sci; 2019 Jan; 124(1):37-41. PubMed ID: 30251577
[TBL] [Abstract][Full Text] [Related]
7. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory.
Weinfurt KP; Hernandez AF; Coronado GD; DeBar LL; Dember LM; Green BB; Heagerty PJ; Huang SS; James KT; Jarvik JG; Larson EB; Mor V; Platt R; Rosenthal GE; Septimus EJ; Simon GE; Staman KL; Sugarman J; Vazquez M; Zatzick D; Curtis LH
BMC Med Res Methodol; 2017 Sep; 17(1):144. PubMed ID: 28923013
[TBL] [Abstract][Full Text] [Related]
8. Series: Pragmatic trials and real world evidence: Paper 5. Usual care and real life comparators.
Zuidgeest MGP; Welsing PMJ; van Thiel GJMW; Ciaglia A; Alfonso-Cristancho R; Eckert L; Eijkemans MJC; Egger M;
J Clin Epidemiol; 2017 Oct; 90():92-98. PubMed ID: 28694123
[TBL] [Abstract][Full Text] [Related]
9. The APPROACH trial: Assessing pain, patient-reported outcomes, and complementary and integrative health.
Zeliadt SB; Coggeshall S; Thomas E; Gelman H; Taylor SL
Clin Trials; 2020 Aug; 17(4):351-359. PubMed ID: 32522024
[TBL] [Abstract][Full Text] [Related]
10. Real-world Data for Clinical Evidence Generation in Oncology.
Khozin S; Blumenthal GM; Pazdur R
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059439
[TBL] [Abstract][Full Text] [Related]
11. Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real world.
Welsing PM; Oude Rengerink K; Collier S; Eckert L; van Smeden M; Ciaglia A; Nachbaur G; Trelle S; Taylor AJ; Egger M; Goetz I;
J Clin Epidemiol; 2017 Oct; 90():99-107. PubMed ID: 28502810
[TBL] [Abstract][Full Text] [Related]
12. Pragmatic randomised clinical trials using electronic health records: general practitioner views on a model of a priori consent.
Hills T; Semprini A; Beasley R
Trials; 2018 May; 19(1):278. PubMed ID: 29769088
[TBL] [Abstract][Full Text] [Related]
13. Series: Pragmatic trials and real world evidence: Paper 2. Setting, sites, and investigator selection.
Worsley SD; Oude Rengerink K; Irving E; Lejeune S; Mol K; Collier S; Groenwold RHH; Enters-Weijnen C; Egger M; Rhodes T;
J Clin Epidemiol; 2017 Aug; 88():14-20. PubMed ID: 28502811
[TBL] [Abstract][Full Text] [Related]
14. Optimizing the design of pragmatic trials: key issues remain.
Caro JJ; Ishak KJ
J Comp Eff Res; 2012 Jul; 1(4):319-27. PubMed ID: 24237466
[TBL] [Abstract][Full Text] [Related]
15. Pragmatic study designs for older adults with cancer: Report from the U13 conference.
Nipp RD; Yao NA; Lowenstein LM; Buckner JC; Parker IR; Gajra A; Morrison VA; Dale W; Ballman KV
J Geriatr Oncol; 2016 Jul; 7(4):234-41. PubMed ID: 27197914
[TBL] [Abstract][Full Text] [Related]
16. Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems.
Larson EB; Tachibana C; Thompson E; Coronado GD; DeBar L; Dember LM; Honda S; Huang SS; Jarvik JG; Nelson C; Septimus E; Simon G; Johnson KE
Healthc (Amst); 2016 Sep; 4(3):138-41. PubMed ID: 27637816
[TBL] [Abstract][Full Text] [Related]
17. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
Dal-Ré R; Janiaud P; Ioannidis JPA
BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers.
Sonnad SS; Mullins CD; Whicher D; Goldsack JC; Mohr PE; Tunis SR
Contemp Clin Trials; 2013 Nov; 36(2):356-61. PubMed ID: 23999501
[TBL] [Abstract][Full Text] [Related]
19. Lessons learned in methods and analyses for pragmatic studies.
Eckardt P; Erlanger AE
Nurs Outlook; 2018 Sep; 66(5):446-454. PubMed ID: 30131168
[TBL] [Abstract][Full Text] [Related]
20. Designing pragmatic trials-what can we learn from lessons learned?
Groenwold RHH; Dekkers OM
J Clin Epidemiol; 2017 Oct; 90():3-5. PubMed ID: 28629700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
